WGS
Ticker
GeneDx Holdings Corp
Company
Diagnostics
Industry
Healthcare
Sector
Financial Ratio Analysis
2018
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”47.1%-8.6%18.3%10.6%-13.7%50.8%β€”50.5%
Revenue Growth QoQ
β€”47.1%-8.6%18.3%10.6%-13.7%50.8%β€”β€”
Gross Margin
30.9%42.2%2.2%-7.8%-11.4%44.4%63.6%β€”69.6%
EBITDA Margin
-17.4%-12.2%-128.4%-200.0%-259.2%-72.5%-0.4%β€”8.4%
Operating Margin
-21.5%-15.5%-134.9%-210.3%-284.5%-89.2%-7.6%β€”2.5%
Profit Margin
-17.9%-15.1%-134.6%-115.6%-233.9%-86.8%-17.1%β€”0.5%
FCF / EBITDA
123.2%142.4%54.3%49.8%54.8%126.6%2697.4%β€”45.7%